Notable laboratory test results are shown below: Component Result Hemoglobin, g/dL INR Total bilirubin, mg/dL Direct bilirubin, mg/dL AST, U/L ALT, U/L ALP, U/L 8.6 2.8 13.2 4.5 109 128 75 Results of abdominal ultrasonography and additional serologies, including laboratory tests for viral hepatitis, are pending
Q6: What are the reported side effects of DSIP
First, youll want to tap the top of the ampoule gently to make sure all the liquid settles in the bottom portion
Currently Available Treatment Tirzepatide FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential Retatrutide Phase 3 TRIUMPH-4 data showed 28.7% weight loss at 68 weeks (24.2% at 48 weeks in Phase 2), exceeding tirzepatide's results Non-Alcoholic Fatty Liver Disease Retatrutide Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management Tirzepatide Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
